4.3 Article

Pregnancy outcomes among Egyptian women with systemic lupus erythematosus: A prospective cohort study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data

Megan E. B. Clowse et al.

Summary: This individual patient data meta-analysis found that continuing hydroxychloroquine (HCQ) use during pregnancy can decrease lupus activity and has no harm on pregnancy outcomes in women with systemic lupus erythematosus (SLE) pregnancies.

LUPUS SCIENCE & MEDICINE (2022)

Article Rheumatology

Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort

Valeria Erazo-Martinez et al.

Summary: Pregnant women with SLE have a higher risk of maternal complications, including preterm labor, preeclampsia, and preterm rupture of membranes. Disease activity and lupus nephritis in SLE may lead to adverse maternal outcomes.
Article Rheumatology

The importance of pregnancy planning in lupus pregnancies

Aardra Rajendran et al.

Summary: This study explores the association between pregnancy planning, recommended behaviors, and pregnancy outcomes in women with lupus. Results show that not-planned pregnancies are associated with poorer outcomes, particularly in women who are ambivalent about pregnancy. Effective pregnancy planning and contraception guidance may decrease the risk for maternal-fetal morbidity and mortality in this high-risk population.
Article Pharmacology & Pharmacy

SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy

Maddalena Larosa et al.

Summary: This study observed 158 pregnant women with SLE and found a significant correlation between SLE-DAS and SLEPDAI. The use of SLE-DAS in the first trimester predicted maternal flares in the 2nd and 3rd trimester, demonstrating its reliability in measuring SLE activity during pregnancy.

FRONTIERS IN PHARMACOLOGY (2021)

Review Obstetrics & Gynecology

Biochemical and clinical predictors in pregnant women with antiphospholipid syndrome and systemic lupus erythematosus: comprehensive update

Xiaodong Li et al.

Summary: Autoimmune diseases such as APS and SLE can lead to maternal complications, including lupus flare, hypertension, nephritis, and preeclampsia. The main treatment for APS is low molecular weight heparin and aspirin, with a success rate of around 75%. Research also indicates the safety and efficacy of hydroxychloroquine in preventing adverse pregnancy outcomes.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)

Review Obstetrics & Gynecology

Pregnancy and Systemic Lupus Erythematosus

Michelle Petri

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)

Article Medicine, General & Internal

Predictors of Pregnancy Outcomes in Patients With Lupus A Cohort Study

Jill P. Buyon et al.

ANNALS OF INTERNAL MEDICINE (2015)

Article Medicine, General & Internal

Pregnancy Outcomes and Appropriate Timing of Pregnancy in 183 pregnancies in Korean Patients with SLE

Hyun Sun Ko et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2011)

Article Rheumatology

Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis

Kate Bramham et al.

JOURNAL OF RHEUMATOLOGY (2011)

Review Rheumatology

Managing pregnancy in inflammatory rheumatological diseases

Varsha Jain et al.

ARTHRITIS RESEARCH & THERAPY (2011)

Review Urology & Nephrology

A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

Andrew Smyth et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)